On Invalid Date, Lisata Therapeutics (NASDAQ: LSTA) reported Q4 2023 earnings per share (EPS) of -$0.66, up 181.48% year over year. Total Lisata Therapeutics earnings for the quarter were -$5.37 million. In the same quarter last year, Lisata Therapeutics's earnings per share (EPS) was $0.81.
As of Q2 2024, Lisata Therapeutics's earnings has grown year over year. Lisata Therapeutics's earnings in the past year totalled -$20.84 million.
What is LSTA's earnings date?
Lisata Therapeutics's earnings date is Invalid Date. Add LSTA to your watchlist to be reminded of LSTA's next earnings announcement.
What was LSTA's revenue last quarter?
On Invalid Date, Lisata Therapeutics (NASDAQ: LSTA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lisata Therapeutics's revenue was $0.00.
What was LSTA's revenue growth in the past year?
As of Q2 2024, Lisata Therapeutics's revenue has grown null year over year. Lisata Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.